Kora Saúde Participações S.A.

B3:KRSA3.SA

0.5 (BRL) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 582.574565.143564.689576.951565.02553.027537.978511.222518.786478.743414.048324.464306.762216.582444.616154.868136.022139.803
Cost of Revenue 478.693454.829462.291479.349438.287428.986430.554402.849375.066350.314334.767237.273214.421152.693267.559120.632101.686104.851
Gross Profit 103.881110.314102.39897.602126.733124.041107.424108.373143.72128.42979.28187.19192.34163.889177.05734.23634.33634.952
Gross Profit Ratio 0.1780.1950.1810.1690.2240.2240.20.2120.2770.2680.1910.2690.3010.2950.3980.2210.2520.25
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 14.22410.95112.17614.15115.2666.3783.6275.8595.9064.9670.0144.3021.8661.231138.6961.30116.11520.472
Selling & Marketing Expenses 23.337139.5516.41711.400000000000000
SG&A 68.75634.06628.59325.55115.2666.3783.6275.8595.9064.9670.0144.3021.8661.231138.6961.30116.11520.472
Other Expenses -0.128-0.1520.3610.1530.003-0.5-0.46900000000000
Operating Expenses 68.88434.21828.23225.39850.1271.58650.08657.45156.23856.28192.16341.23933.12324.20293.273.09116.56623.166
Operating Income 34.99776.09674.16672.20477.37847.2277.64745.23680.19769.617-19.08935.70653.5939.09490.34332.72817.85514.185
Operating Income Ratio 0.060.1350.1310.1250.1370.0850.0140.0880.1550.145-0.0460.110.1750.1810.2030.2110.1310.101
Total Other Income Expenses Net -61.02-94.659-103.844-101.342-109.079-92.527-74.732-98.634-68.814-50.236-39.548-32.065-20.955-13.899-85.356-9.893-8.875-12.129
Income Before Tax -26.023-18.563-29.678-29.138-31.701-45.3-67.085-53.39811.38319.381-58.6373.64132.63525.1954.98722.8358.982.056
Income Before Tax Ratio -0.045-0.033-0.053-0.051-0.056-0.082-0.125-0.1040.0220.04-0.1420.0110.1060.1160.0110.1470.0660.015
Income Tax Expense 0.6786.607-9.19413.54916.9942.735-8.0632.07610.4490.28716.21318.35812.13211.0862.9569.6722.3791.077
Net Income -27.943-27.864-18.935-45.269-48.695-50.878-63.52-55.435-2.78714.154-78.396-16.29918.33612.6414.18910.3685.3940.655
Net Income Ratio -0.048-0.049-0.034-0.078-0.086-0.092-0.118-0.108-0.0050.03-0.189-0.050.060.0580.0090.0670.040.005
EPS -0.036-0.036-0.025-0.059-0.063-0.066-0.082-0.072-0.0040.018-0.1-0.030.0240.017-00.0140.370.005
EPS Diluted -0.036-0.036-0.025-0.059-0.063-0.066-0.08-0.072-0.0040.018-0.1-0.030.0240.017-00.0140.370.005
EBITDA 70.25112.93122.22116.079114.91985.32854.21586.72893.19992.62511.16253.87370.10647.42998.87236.10422.40620.515
EBITDA Ratio 0.1210.20.2160.2010.2030.1540.1010.170.180.1930.0270.1660.2290.2190.2220.2330.1650.147